Sakra Hospital Expands: Second Bengaluru Facility at Rs 1,000 Crore

India Pharma Outlook Team | Monday, 18 March 2024

 international communities, specialized treatment procedures, India Pharma Outlook

Photo:Representative Image

Sakra World Hospital, a joint venture between SECOM and Toyota Tsusho Corporation (TTC), has announced plans to establish a healthcare facility in Banaswadi, Bengaluru, with an expected investment of Rs 1,000 crore. The facility will span 600,000 square feet and feature 500 beds, with a second phase expansion planned to incorporate a 1,000-bed facility.

Scheduled for completion by 2026, the facility will emphasize its commitment to advancing healthcare regionally and nationally. It will incorporate cutting-edge medical technologies and Indo-Japanese architectural design.

SECOM has revealed that the comprehensive tertiary care unit will offer specialized services from advanced oncology to cutting-edge rehabilitation programs.

"We are proud to combine the expertise of SECOM Medical System and Toyota Tsusho to deliver world-class healthcare solutions in Bengaluru. The new facility is an extension of our firm commitment towards fulfilling the healthcare needs of the local and international communities," said Tatsuro Fuse, executive director of SECOM and chairman of SECOM Medical System, Japan.

The conference highlighted various super-specialties and specialized treatment procedures, such as advanced oncology treatments, robotic surgeries, and innovative rehabilitation programs, to be offered at the upcoming facility.

In collaboration with SECOM and TTC, Sakra expects a revenue surge of Rs 500 crore by the end of 2024.

Sakra World Hospital has also announced its ambitious expansion strategy, including opening new hospitals on Bengaluru's Sarjapur Road or Old Madras Road within the next decade and venturing into Tier II cities. The hospital also plans to develop a 50-bed boutique hospital in HSR Layout.

Sakra World Hospital remains committed to enriching the quality of life for all through its research and education initiatives. "Medical research and education are integral to our growth journey. We believe in fostering a culture of continual learning and innovation," added Lovekesh Phasu, Group Chief Operating Officer of Sakra World Hospital, Bengaluru.

© 2024 India Pharma Outlook. All Rights Reserved.